img

Global Cell Therapy Manufacturing Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Cell Therapy Manufacturing Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Cell Therapy Manufacturing Market
Global Cell Therapy Manufacturing market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Cell Therapy Manufacturing industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Cell Therapy Manufacturing key companies include Merck, Avantor, Cell Therapies, Thermo Fisher Scientific, Charles River Laboratories, Catalent, Bio-Techne, Cytiva and Lonza, etc. Merck, Avantor, Cell Therapies are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Cell Therapy Manufacturing were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Cell Therapy Manufacturing market and estimated to attract more attentions from industry insiders and investors.
Cell Therapy Manufacturing can be divided into Autologous and Allogenic, etc. Autologous is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Cell Therapy Manufacturing is widely used in various fields, such as Clinical, Commercial and Pre-clinical,, etc. Clinical provides greatest supports to the Cell Therapy Manufacturing industry development. In 2022, global % revenue of Cell Therapy Manufacturing went into Clinical filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Cell Therapy Manufacturing market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Cell Therapy Manufacturing market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck
Avantor
Cell Therapies
Thermo Fisher Scientific
Charles River Laboratories
Catalent
Bio-Techne
Cytiva
Lonza
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Novartis
Bristol-Myers Squibb
Gilead
WuXi AppTec
Pharmaron
Aldevron
Exothera
Segment by Type
Autologous
Allogenic

Segment by Application


Clinical
Commercial
Pre-clinical
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Cell Therapy Manufacturing introduction, etc. Cell Therapy Manufacturing Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Cell Therapy Manufacturing
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy Manufacturing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Autologous
1.2.3 Allogenic
1.3 Market by Application
1.3.1 Global Cell Therapy Manufacturing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Clinical
1.3.3 Commercial
1.3.4 Pre-clinical
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy Manufacturing Market Perspective (2018-2033)
2.2 Global Cell Therapy Manufacturing Growth Trends by Region
2.2.1 Cell Therapy Manufacturing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cell Therapy Manufacturing Historic Market Size by Region (2018-2023)
2.2.3 Cell Therapy Manufacturing Forecasted Market Size by Region (2024-2033)
2.3 Cell Therapy Manufacturing Market Dynamics
2.3.1 Cell Therapy Manufacturing Industry Trends
2.3.2 Cell Therapy Manufacturing Market Drivers
2.3.3 Cell Therapy Manufacturing Market Challenges
2.3.4 Cell Therapy Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cell Therapy Manufacturing by Players
3.1.1 Global Cell Therapy Manufacturing Revenue by Players (2018-2023)
3.1.2 Global Cell Therapy Manufacturing Revenue Market Share by Players (2018-2023)
3.2 Global Cell Therapy Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cell Therapy Manufacturing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Cell Therapy Manufacturing Market Concentration Ratio
3.4.1 Global Cell Therapy Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy Manufacturing Revenue in 2022
3.5 Global Key Players of Cell Therapy Manufacturing Head office and Area Served
3.6 Global Key Players of Cell Therapy Manufacturing, Product and Application
3.7 Global Key Players of Cell Therapy Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Therapy Manufacturing Breakdown Data by Type
4.1 Global Cell Therapy Manufacturing Historic Market Size by Type (2018-2023)
4.2 Global Cell Therapy Manufacturing Forecasted Market Size by Type (2024-2033)
5 Cell Therapy Manufacturing Breakdown Data by Application
5.1 Global Cell Therapy Manufacturing Historic Market Size by Application (2018-2023)
5.2 Global Cell Therapy Manufacturing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cell Therapy Manufacturing Market Size (2018-2033)
6.2 North America Cell Therapy Manufacturing Market Size by Type
6.2.1 North America Cell Therapy Manufacturing Market Size by Type (2018-2023)
6.2.2 North America Cell Therapy Manufacturing Market Size by Type (2024-2033)
6.2.3 North America Cell Therapy Manufacturing Market Share by Type (2018-2033)
6.3 North America Cell Therapy Manufacturing Market Size by Application
6.3.1 North America Cell Therapy Manufacturing Market Size by Application (2018-2023)
6.3.2 North America Cell Therapy Manufacturing Market Size by Application (2024-2033)
6.3.3 North America Cell Therapy Manufacturing Market Share by Application (2018-2033)
6.4 North America Cell Therapy Manufacturing Market Size by Country
6.4.1 North America Cell Therapy Manufacturing Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Cell Therapy Manufacturing Market Size by Country (2018-2023)
6.4.3 North America Cell Therapy Manufacturing Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Cell Therapy Manufacturing Market Size (2018-2033)
7.2 Europe Cell Therapy Manufacturing Market Size by Type
7.2.1 Europe Cell Therapy Manufacturing Market Size by Type (2018-2023)
7.2.2 Europe Cell Therapy Manufacturing Market Size by Type (2024-2033)
7.2.3 Europe Cell Therapy Manufacturing Market Share by Type (2018-2033)
7.3 Europe Cell Therapy Manufacturing Market Size by Application
7.3.1 Europe Cell Therapy Manufacturing Market Size by Application (2018-2023)
7.3.2 Europe Cell Therapy Manufacturing Market Size by Application (2024-2033)
7.3.3 Europe Cell Therapy Manufacturing Market Share by Application (2018-2033)
7.4 Europe Cell Therapy Manufacturing Market Size by Country
7.4.1 Europe Cell Therapy Manufacturing Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Cell Therapy Manufacturing Market Size by Country (2018-2023)
7.4.3 Europe Cell Therapy Manufacturing Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cell Therapy Manufacturing Market Size (2018-2033)
8.2 China Cell Therapy Manufacturing Market Size by Type
8.2.1 China Cell Therapy Manufacturing Market Size by Type (2018-2023)
8.2.2 China Cell Therapy Manufacturing Market Size by Type (2024-2033)
8.2.3 China Cell Therapy Manufacturing Market Share by Type (2018-2033)
8.3 China Cell Therapy Manufacturing Market Size by Application
8.3.1 China Cell Therapy Manufacturing Market Size by Application (2018-2023)
8.3.2 China Cell Therapy Manufacturing Market Size by Application (2024-2033)
8.3.3 China Cell Therapy Manufacturing Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Cell Therapy Manufacturing Market Size (2018-2033)
9.2 Asia Cell Therapy Manufacturing Market Size by Type
9.2.1 Asia Cell Therapy Manufacturing Market Size by Type (2018-2023)
9.2.2 Asia Cell Therapy Manufacturing Market Size by Type (2024-2033)
9.2.3 Asia Cell Therapy Manufacturing Market Share by Type (2018-2033)
9.3 Asia Cell Therapy Manufacturing Market Size by Application
9.3.1 Asia Cell Therapy Manufacturing Market Size by Application (2018-2023)
9.3.2 Asia Cell Therapy Manufacturing Market Size by Application (2024-2033)
9.3.3 Asia Cell Therapy Manufacturing Market Share by Application (2018-2033)
9.4 Asia Cell Therapy Manufacturing Market Size by Region
9.4.1 Asia Cell Therapy Manufacturing Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Cell Therapy Manufacturing Market Size by Region (2018-2023)
9.4.3 Asia Cell Therapy Manufacturing Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Cell Therapy Manufacturing Introduction
11.1.4 Merck Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.1.5 Merck Recent Developments
11.2 Avantor
11.2.1 Avantor Company Details
11.2.2 Avantor Business Overview
11.2.3 Avantor Cell Therapy Manufacturing Introduction
11.2.4 Avantor Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.2.5 Avantor Recent Developments
11.3 Cell Therapies
11.3.1 Cell Therapies Company Details
11.3.2 Cell Therapies Business Overview
11.3.3 Cell Therapies Cell Therapy Manufacturing Introduction
11.3.4 Cell Therapies Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.3.5 Cell Therapies Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Cell Therapy Manufacturing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Details
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories Cell Therapy Manufacturing Introduction
11.5.4 Charles River Laboratories Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.5.5 Charles River Laboratories Recent Developments
11.6 Catalent
11.6.1 Catalent Company Details
11.6.2 Catalent Business Overview
11.6.3 Catalent Cell Therapy Manufacturing Introduction
11.6.4 Catalent Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.6.5 Catalent Recent Developments
11.7 Bio-Techne
11.7.1 Bio-Techne Company Details
11.7.2 Bio-Techne Business Overview
11.7.3 Bio-Techne Cell Therapy Manufacturing Introduction
11.7.4 Bio-Techne Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.7.5 Bio-Techne Recent Developments
11.8 Cytiva
11.8.1 Cytiva Company Details
11.8.2 Cytiva Business Overview
11.8.3 Cytiva Cell Therapy Manufacturing Introduction
11.8.4 Cytiva Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.8.5 Cytiva Recent Developments
11.9 Lonza
11.9.1 Lonza Company Details
11.9.2 Lonza Business Overview
11.9.3 Lonza Cell Therapy Manufacturing Introduction
11.9.4 Lonza Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.9.5 Lonza Recent Developments
11.10 BIOCENTRIQ
11.10.1 BIOCENTRIQ Company Details
11.10.2 BIOCENTRIQ Business Overview
11.10.3 BIOCENTRIQ Cell Therapy Manufacturing Introduction
11.10.4 BIOCENTRIQ Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.10.5 BIOCENTRIQ Recent Developments
11.11 FUJIFILM Diosynth Biotechnologies
11.11.1 FUJIFILM Diosynth Biotechnologies Company Details
11.11.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.11.3 FUJIFILM Diosynth Biotechnologies Cell Therapy Manufacturing Introduction
11.11.4 FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.11.5 FUJIFILM Diosynth Biotechnologies Recent Developments
11.12 Novartis
11.12.1 Novartis Company Details
11.12.2 Novartis Business Overview
11.12.3 Novartis Cell Therapy Manufacturing Introduction
11.12.4 Novartis Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.12.5 Novartis Recent Developments
11.13 Bristol-Myers Squibb
11.13.1 Bristol-Myers Squibb Company Details
11.13.2 Bristol-Myers Squibb Business Overview
11.13.3 Bristol-Myers Squibb Cell Therapy Manufacturing Introduction
11.13.4 Bristol-Myers Squibb Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.13.5 Bristol-Myers Squibb Recent Developments
11.14 Gilead
11.14.1 Gilead Company Details
11.14.2 Gilead Business Overview
11.14.3 Gilead Cell Therapy Manufacturing Introduction
11.14.4 Gilead Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.14.5 Gilead Recent Developments
11.15 WuXi AppTec
11.15.1 WuXi AppTec Company Details
11.15.2 WuXi AppTec Business Overview
11.15.3 WuXi AppTec Cell Therapy Manufacturing Introduction
11.15.4 WuXi AppTec Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.15.5 WuXi AppTec Recent Developments
11.16 Pharmaron
11.16.1 Pharmaron Company Details
11.16.2 Pharmaron Business Overview
11.16.3 Pharmaron Cell Therapy Manufacturing Introduction
11.16.4 Pharmaron Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.16.5 Pharmaron Recent Developments
11.17 Aldevron
11.17.1 Aldevron Company Details
11.17.2 Aldevron Business Overview
11.17.3 Aldevron Cell Therapy Manufacturing Introduction
11.17.4 Aldevron Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.17.5 Aldevron Recent Developments
11.18 Exothera
11.18.1 Exothera Company Details
11.18.2 Exothera Business Overview
11.18.3 Exothera Cell Therapy Manufacturing Introduction
11.18.4 Exothera Revenue in Cell Therapy Manufacturing Business (2018-2023)
11.18.5 Exothera Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cell Therapy Manufacturing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Autologous
Table 3. Key Players of Allogenic
Table 4. Global Cell Therapy Manufacturing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Cell Therapy Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Cell Therapy Manufacturing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Cell Therapy Manufacturing Market Share by Region (2018-2023)
Table 8. Global Cell Therapy Manufacturing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Cell Therapy Manufacturing Market Share by Region (2024-2033)
Table 10. Cell Therapy Manufacturing Market Trends
Table 11. Cell Therapy Manufacturing Market Drivers
Table 12. Cell Therapy Manufacturing Market Challenges
Table 13. Cell Therapy Manufacturing Market Restraints
Table 14. Global Cell Therapy Manufacturing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Cell Therapy Manufacturing Revenue Share by Players (2018-2023)
Table 16. Global Top Cell Therapy Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy Manufacturing as of 2022)
Table 17. Global Cell Therapy Manufacturing Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Cell Therapy Manufacturing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Cell Therapy Manufacturing, Headquarters and Area Served
Table 20. Global Key Players of Cell Therapy Manufacturing, Product and Application
Table 21. Global Key Players of Cell Therapy Manufacturing, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Therapy Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Cell Therapy Manufacturing Revenue Market Share by Type (2018-2023)
Table 25. Global Cell Therapy Manufacturing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Cell Therapy Manufacturing Revenue Market Share by Type (2024-2033)
Table 27. Global Cell Therapy Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Cell Therapy Manufacturing Revenue Share by Application (2018-2023)
Table 29. Global Cell Therapy Manufacturing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Cell Therapy Manufacturing Revenue Share by Application (2024-2033)
Table 31. North America Cell Therapy Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Cell Therapy Manufacturing Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Cell Therapy Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Cell Therapy Manufacturing Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Cell Therapy Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Cell Therapy Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Cell Therapy Manufacturing Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Cell Therapy Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Cell Therapy Manufacturing Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Cell Therapy Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Cell Therapy Manufacturing Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Cell Therapy Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Cell Therapy Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Cell Therapy Manufacturing Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Cell Therapy Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Cell Therapy Manufacturing Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Cell Therapy Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Cell Therapy Manufacturing Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Cell Therapy Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Cell Therapy Manufacturing Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Cell Therapy Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Cell Therapy Manufacturing Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Cell Therapy Manufacturing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Cell Therapy Manufacturing Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Cell Therapy Manufacturing Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Cell Therapy Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size by Country (2024-2033) & (US$ Million)
Table 63. Merck Company Details
Table 64. Merck Business Overview
Table 65. Merck Cell Therapy Manufacturing Product
Table 66. Merck Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 67. Merck Recent Developments
Table 68. Avantor Company Details
Table 69. Avantor Business Overview
Table 70. Avantor Cell Therapy Manufacturing Product
Table 71. Avantor Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 72. Avantor Recent Developments
Table 73. Cell Therapies Company Details
Table 74. Cell Therapies Business Overview
Table 75. Cell Therapies Cell Therapy Manufacturing Product
Table 76. Cell Therapies Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 77. Cell Therapies Recent Developments
Table 78. Thermo Fisher Scientific Company Details
Table 79. Thermo Fisher Scientific Business Overview
Table 80. Thermo Fisher Scientific Cell Therapy Manufacturing Product
Table 81. Thermo Fisher Scientific Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 82. Thermo Fisher Scientific Recent Developments
Table 83. Charles River Laboratories Company Details
Table 84. Charles River Laboratories Business Overview
Table 85. Charles River Laboratories Cell Therapy Manufacturing Product
Table 86. Charles River Laboratories Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 87. Charles River Laboratories Recent Developments
Table 88. Catalent Company Details
Table 89. Catalent Business Overview
Table 90. Catalent Cell Therapy Manufacturing Product
Table 91. Catalent Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 92. Catalent Recent Developments
Table 93. Bio-Techne Company Details
Table 94. Bio-Techne Business Overview
Table 95. Bio-Techne Cell Therapy Manufacturing Product
Table 96. Bio-Techne Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 97. Bio-Techne Recent Developments
Table 98. Cytiva Company Details
Table 99. Cytiva Business Overview
Table 100. Cytiva Cell Therapy Manufacturing Product
Table 101. Cytiva Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 102. Cytiva Recent Developments
Table 103. Lonza Company Details
Table 104. Lonza Business Overview
Table 105. Lonza Cell Therapy Manufacturing Product
Table 106. Lonza Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 107. Lonza Recent Developments
Table 108. BIOCENTRIQ Company Details
Table 109. BIOCENTRIQ Business Overview
Table 110. BIOCENTRIQ Cell Therapy Manufacturing Product
Table 111. BIOCENTRIQ Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 112. BIOCENTRIQ Recent Developments
Table 113. FUJIFILM Diosynth Biotechnologies Company Details
Table 114. FUJIFILM Diosynth Biotechnologies Business Overview
Table 115. FUJIFILM Diosynth Biotechnologies Cell Therapy Manufacturing Product
Table 116. FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 117. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 118. Novartis Company Details
Table 119. Novartis Business Overview
Table 120. Novartis Cell Therapy Manufacturing Product
Table 121. Novartis Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 122. Novartis Recent Developments
Table 123. Bristol-Myers Squibb Company Details
Table 124. Bristol-Myers Squibb Business Overview
Table 125. Bristol-Myers Squibb Cell Therapy Manufacturing Product
Table 126. Bristol-Myers Squibb Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 127. Bristol-Myers Squibb Recent Developments
Table 128. Gilead Company Details
Table 129. Gilead Business Overview
Table 130. Gilead Cell Therapy Manufacturing Product
Table 131. Gilead Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 132. Gilead Recent Developments
Table 133. WuXi AppTec Company Details
Table 134. WuXi AppTec Business Overview
Table 135. WuXi AppTec Cell Therapy Manufacturing Product
Table 136. WuXi AppTec Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 137. WuXi AppTec Recent Developments
Table 138. Pharmaron Company Details
Table 139. Pharmaron Business Overview
Table 140. Pharmaron Cell Therapy Manufacturing Product
Table 141. Pharmaron Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 142. Pharmaron Recent Developments
Table 143. Aldevron Company Details
Table 144. Aldevron Business Overview
Table 145. Aldevron Cell Therapy Manufacturing Product
Table 146. Aldevron Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 147. Aldevron Recent Developments
Table 148. Exothera Company Details
Table 149. Exothera Business Overview
Table 150. Exothera Cell Therapy Manufacturing Product
Table 151. Exothera Revenue in Cell Therapy Manufacturing Business (2018-2023) & (US$ Million)
Table 152. Exothera Recent Developments
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Therapy Manufacturing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Cell Therapy Manufacturing Market Share by Type: 2022 VS 2033
Figure 3. Autologous Features
Figure 4. Allogenic Features
Figure 5. Global Cell Therapy Manufacturing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Cell Therapy Manufacturing Market Share by Application: 2022 VS 2033
Figure 7. Clinical Case Studies
Figure 8. Commercial Case Studies
Figure 9. Pre-clinical Case Studies
Figure 10. Cell Therapy Manufacturing Report Years Considered
Figure 11. Global Cell Therapy Manufacturing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Cell Therapy Manufacturing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Cell Therapy Manufacturing Market Share by Region: 2022 VS 2033
Figure 14. Global Cell Therapy Manufacturing Market Share by Players in 2022
Figure 15. Global Top Cell Therapy Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy Manufacturing as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Cell Therapy Manufacturing Revenue in 2022
Figure 17. North America Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Cell Therapy Manufacturing Market Share by Type (2018-2033)
Figure 19. North America Cell Therapy Manufacturing Market Share by Application (2018-2033)
Figure 20. North America Cell Therapy Manufacturing Market Share by Country (2018-2033)
Figure 21. United States Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Cell Therapy Manufacturing Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Cell Therapy Manufacturing Market Share by Type (2018-2033)
Figure 25. Europe Cell Therapy Manufacturing Market Share by Application (2018-2033)
Figure 26. Europe Cell Therapy Manufacturing Market Share by Country (2018-2033)
Figure 27. Germany Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Cell Therapy Manufacturing Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Cell Therapy Manufacturing Market Share by Type (2018-2033)
Figure 35. China Cell Therapy Manufacturing Market Share by Application (2018-2033)
Figure 36. Asia Cell Therapy Manufacturing Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Cell Therapy Manufacturing Market Share by Type (2018-2033)
Figure 38. Asia Cell Therapy Manufacturing Market Share by Application (2018-2033)
Figure 39. Asia Cell Therapy Manufacturing Market Share by Region (2018-2033)
Figure 40. Japan Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Cell Therapy Manufacturing Market Share by Country (2018-2033)
Figure 50. Brazil Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Cell Therapy Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Merck Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 57. Avantor Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 58. Cell Therapies Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 60. Charles River Laboratories Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 61. Catalent Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 62. Bio-Techne Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 63. Cytiva Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 64. Lonza Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 65. BIOCENTRIQ Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 66. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 67. Novartis Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 69. Gilead Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 70. WuXi AppTec Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 71. Pharmaron Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 72. Aldevron Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 73. Exothera Revenue Growth Rate in Cell Therapy Manufacturing Business (2018-2023)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed